Distinct seromarkers predict different milestones of chronic hepatitis B progression-Reference-Cited by-同舟云学术

Distinct seromarkers predict different milestones of chronic hepatitis B progression

Published:2014-05-28 Issue:1 Volume:60 Page:77-86
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Liu Jessica¹,Yang Hwai-I¹²³,Lee Mei-Hsuan⁴,Batrla-Utermann Richard⁵,Jen Chin-Lan¹,Lu Sheng-Nan⁶,Wang Li-Yu⁷,You San-Lin¹,Hsiao Chuhsing Kate⁸,Chen Chien-Jen¹⁸,

Affiliation:

1. Genomics Research Center; Academia Sinica; Taipei Taiwan

2. Molecular and Genomic Epidemiology Center; China Medical University Hospital; Taichung Taiwan

3. Graduate Institute of Clinical Medical Science; China Medical University; Taichung Taiwan

4. Institute of Clinical Medicine; National Yang Ming University; Taipei Taiwan

5. Roche Diagnostics, Ltd; Switzerland

6. Department of Gastroenterology; Chang-Gung Memorial Hospital; Kaohsiung Taiwan

7. MacKay College of Medicine; Taipei Taiwan

8. Graduate Institute of Epidemiology and Preventative Medicine; College of Public Health, National Taiwan University; Taipei Taiwan

Funder

Department of Health, Executive Yuan

National Health Research Institute

Publisher

Wiley

Subject

Hepatology

Reference30 articles.

1. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures;Lavanchy;J Viral Hepat,2004

2. Hepatitis B virus infection;Liaw;Lancet,2009

3. Natural history of chronic hepatitis B REVEALed;Chen;J Gastroenterol Hepatol,2011

4. Incidence and determinants of spontaneous seroclearance of hepatitis B e antigen and DNA in patients with chronic hepatitis B;Yang;Clin Gastroenterol Hepatol,2012

5. Diagnostic markers of chronic hepatitis B infection and disease;Bonino;Antivir Ther,2010

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of Phyllanthus urinaria L. in the treatment of liver disease: viral hepatitis, liver fibrosis/cirrhosis and hepatocellular carcinoma;Frontiers in Pharmacology;2024-08-09

2. Quantitative HBV Core Antibodies as a Prognostic Marker for HBeAg Seroclearance: A Systematic Review with Meta-Analysis;Viruses;2024-07-12

3. Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA;Emerging Microbes & Infections;2024-04-16

4. Baseline Hepatitis B Virus Surface Antigen Titers in Childhood Predict the Risk of Advanced Liver Fibrosis in Adulthood;Clinical Gastroenterology and Hepatology;2023-03

5. Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas;Viruses;2023-01-28